COMPOSITION CONTAINING PROGESTIN, PHYTOESTROGEN, ESTROGEN AND VITAMIN D COMPOUND
First Claim
1. A composition comprising a phytoestrogen compound, a progestin, an estrogen, and a Vitamin D compound, said estrogen selected from the group consisting of estrone, estrone sulfate, estrone sulfate piperazine salt, estradiol and estriol, and their esters, mestranol, conjugated equine estrogen, esterified estrogens, estropipate, 17α
- -ethinylestradiol, esters and ethers of 17α
-ethinylestradiol, 17beta-estradiol, estradiol valerate, piperazine estrone sulphate, estriol succinate, and polyestrol phosphate.
0 Assignments
0 Petitions
Accused Products
Abstract
A composition comprising a progestin, a phytoestrogen compound, an estrogen, and a Vitamin D compound. The phytoestrogen is preferably an isoflavone compound selected from the group consisting of daidzein, genistein, and glycitein and their conjugated forms. The progestin is preferably selected from the group consisting of norgestimate in the range of 0.18-0.25 mg, levonorgestrel in the range of 0.05-0.3 mg, norgestrel in the range of 0.075-0.5 mg, norethindrone in the range of 0.5-1.0 mg, desogestrel in the range of 0.06-0.15 mg, gestodene in the range of 0.04-0.12 mg, dienogest in the range of 0.25-4.0 mg, drospirenone in the range of 0.25-4.0 mg, and medroxy-progesterone acetate in the range of 2.5-10 mg. The estrogen is preferably from the group consisting of ethinyl estradiol, 17α-ethinylestradiol, 17beta-estradiol and conjugated estrogens. The Vitamin D compound is preferably at a dosage of at least 400 IU.
-
Citations
25 Claims
-
1. A composition comprising a phytoestrogen compound, a progestin, an estrogen, and a Vitamin D compound, said estrogen selected from the group consisting of estrone, estrone sulfate, estrone sulfate piperazine salt, estradiol and estriol, and their esters, mestranol, conjugated equine estrogen, esterified estrogens, estropipate, 17α
- -ethinylestradiol, esters and ethers of 17α
-ethinylestradiol, 17beta-estradiol, estradiol valerate, piperazine estrone sulphate, estriol succinate, and polyestrol phosphate. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
- -ethinylestradiol, esters and ethers of 17α
-
9. A composition comprising an isoflavone, a progestin and an estrogen, said estrogen selected from the group consisting of estrone, estrone sulfate, estrone sulfate piperazine salt, estradiol and estriol, and their esters, ethinyl estradiol, mestranol, conjugated equine estrogen, esterified estrogens, estropipate, 17α
- -ethinylestradiol, esters and ethers of 17α
-ethinylestradiol, 17beta-estradiol, estradiol valerate, piperazine estrone sulphate, estriol succinate, and polyestrol phosphate. - View Dependent Claims (10, 11)
- -ethinylestradiol, esters and ethers of 17α
-
12. A composition comprising genistein, a progestin, and an estrogen, said estrogen selected from the group consisting of estrone, estrone sulfate, estrone sulfate piperazine salt, estradiol and estriol, and their esters, ethinyl estradiol, mestranol, conjugated equine estrogen, esterified estrogens, estropipate, 17α
- -ethinylestradiol, esters and ethers of 17α
-ethinylestradiol, 17beta-estradiol, estradiol valerate, piperazine estrone sulphate, estriol succinate, and polyestrol phosphate. - View Dependent Claims (13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)
- -ethinylestradiol, esters and ethers of 17α
-
25. A composition comprising an isoflavone compound, a progestin, a Vitamin D compound, and an estrogen, said estrogen selected from the group consisting of estrone, estrone sulfate, estrone sulfate piperazine salt, estradiol and estriol, and their esters, mestranol, conjugated equine estrogen, esterified estrogens, estropipate, 17α
- -ethinylestradiol, esters and ethers of 17α
-ethinylestradiol, 17beta-estradiol, estradiol valerate, piperazine estrone sulphate, estriol succinate, and polyestrol phosphate, wherein the dosage of said isoflavone compound is at least 20 mg and said isoflavone compound is selected from the group consisting of genistein, forms of genistin, and combinations thereof, and wherein said progestin is selected from the group consisting of norgestimate in the range of 0.18-0.25 mg, levonorgestrel in the range of 0.05-0.3 mg, norgestrel in the range of 0.075-0.5 mg, norethindrone in the range of 0.5-1.0 mg, desogestrel in the range of 0.06-0.15 mg, gestodene in the range of 0.04-0.12 mg, and dienogest in the range of 0.25-4.0 mg, medroxy-progesterone acetate in the range of 2.5-10 mg, and drospirenone in the range of 0.25-4.0 mg, and the Vitamin D compound is at a dosage of at least 400 IU and is selected from the group consisting of cholecalciferol, ergocalciferol, and 25-hydroxyvitamin D3.
- -ethinylestradiol, esters and ethers of 17α
Specification